A New Method of Antibiotyping Yeasts for Subspecies Discrimination and Distribution in Human Clinical Specimens

A study of the antibiotypes of 764 isolates of the genera Candida and Torulopsis from different clinical specimens is reported. The typing method was based on the susceptibility results obtained by the standardized and partially automated kit ATB-Fungus (API-bioMérieux), giving to each strain a code...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of epidemiology 1996-02, Vol.12 (1), p.55-62
Hauptverfasser: Quindós, Guillermo, Lipperheide, Verónica, Barturen, Begoña, Alonso, Rocío, Bikandi, Joseba, San Millán, Rosario, Tellaetxe, Matilde, Ribacoba, Laureano, Pontón, José
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 62
container_issue 1
container_start_page 55
container_title European journal of epidemiology
container_volume 12
creator Quindós, Guillermo
Lipperheide, Verónica
Barturen, Begoña
Alonso, Rocío
Bikandi, Joseba
San Millán, Rosario
Tellaetxe, Matilde
Ribacoba, Laureano
Pontón, José
description A study of the antibiotypes of 764 isolates of the genera Candida and Torulopsis from different clinical specimens is reported. The typing method was based on the susceptibility results obtained by the standardized and partially automated kit ATB-Fungus (API-bioMérieux), giving to each strain a code of six figures, according to these criteria: susceptibility to 5-fluorocytosine, amphotericin B, nystatin, miconazole, econazole, and ketoconazole. Candida albicans serotypes were determined by the Candida Check test (Iatron, Japan). Twenty-six antibiotypes were found in C. albicans (482 isolates), 21 types in serotype A, and 15 in serotype B strains. Candida parapsilosis (115 isolates) was divided into 11 antibiotypes, Torulopsis glabrata (53 isolates) into five, Candida guilliermondii (36 isolates) into 10 and Candida tropicalis (31 isolates) into eight. Depending on the sample origin, 000000 (susceptibility to all the antifungals tested) was the predominant C. albicans antibiotype (92.9% of blood isolates, 41.2% of vaginal isolates, 33.3% of respiratory isolates, 31.01% or oral and digestive tract isolates, and 25.0% of nail and skin isolates). No predominant antibiotypes were found in strains from respiratory tract, skin ad nails. A reproducibility close to 99% was found with the test. Simplicity and standardization could make this method useful for typing Candida and Torulopsis isolates.
doi_str_mv 10.1007/BF00144429
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_78353845</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>3582102</jstor_id><sourcerecordid>3582102</sourcerecordid><originalsourceid>FETCH-LOGICAL-c363t-ead8e5f5875b5aec7f9656ff3f363f71e45c533ef37e4f16bd08368b8ef132b33</originalsourceid><addsrcrecordid>eNqFkUFP3DAQhS3Uii60F85U8qHigJTW9sSxc9wu0K1EywF64BQ5ybg1SuzFdlTx75tlV3DsaaR53zyN3iPkhLPPnDH15esVY7wsS1EfkAWXCgoldPmGLBjUUIi6Zu_IUUoPjDHNanlIDrXmiqt6QcKS_sS_9AfmP6GnwdKlz651IT9tnP9N79GknKgNkd5Obdpg5zDRC5e66EbnTXbBU-P77SpH107PC-fpehqNp6vBedeZgd5uL0f06T15a82Q8MN-HpNfV5d3q3VxffPt-2p5XXRQQS7Q9BqllVrJVhrslK0rWVkLdpat4ljKTgKgBYWl5VXbMw2VbjVaDqIFOCZnO99NDI8TptyM89M4DMZjmFKjNEjQpfwvyGUltai2juc7sIshpYi22cwZmPjUcNZsa2hea5jhj3vXqR2xf0H3uc_6p71u0pyPjcZ3Lr1gwEWphJix0x32kHKIr_L8EWcC_gGWDpjW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15658263</pqid></control><display><type>article</type><title>A New Method of Antibiotyping Yeasts for Subspecies Discrimination and Distribution in Human Clinical Specimens</title><source>MEDLINE</source><source>SpringerNature Journals</source><source>JSTOR Archive Collection A-Z Listing</source><creator>Quindós, Guillermo ; Lipperheide, Verónica ; Barturen, Begoña ; Alonso, Rocío ; Bikandi, Joseba ; San Millán, Rosario ; Tellaetxe, Matilde ; Ribacoba, Laureano ; Pontón, José</creator><creatorcontrib>Quindós, Guillermo ; Lipperheide, Verónica ; Barturen, Begoña ; Alonso, Rocío ; Bikandi, Joseba ; San Millán, Rosario ; Tellaetxe, Matilde ; Ribacoba, Laureano ; Pontón, José</creatorcontrib><description>A study of the antibiotypes of 764 isolates of the genera Candida and Torulopsis from different clinical specimens is reported. The typing method was based on the susceptibility results obtained by the standardized and partially automated kit ATB-Fungus (API-bioMérieux), giving to each strain a code of six figures, according to these criteria: susceptibility to 5-fluorocytosine, amphotericin B, nystatin, miconazole, econazole, and ketoconazole. Candida albicans serotypes were determined by the Candida Check test (Iatron, Japan). Twenty-six antibiotypes were found in C. albicans (482 isolates), 21 types in serotype A, and 15 in serotype B strains. Candida parapsilosis (115 isolates) was divided into 11 antibiotypes, Torulopsis glabrata (53 isolates) into five, Candida guilliermondii (36 isolates) into 10 and Candida tropicalis (31 isolates) into eight. Depending on the sample origin, 000000 (susceptibility to all the antifungals tested) was the predominant C. albicans antibiotype (92.9% of blood isolates, 41.2% of vaginal isolates, 33.3% of respiratory isolates, 31.01% or oral and digestive tract isolates, and 25.0% of nail and skin isolates). No predominant antibiotypes were found in strains from respiratory tract, skin ad nails. A reproducibility close to 99% was found with the test. Simplicity and standardization could make this method useful for typing Candida and Torulopsis isolates.</description><identifier>ISSN: 0393-2990</identifier><identifier>ISSN: 0392-2990</identifier><identifier>EISSN: 1573-7284</identifier><identifier>DOI: 10.1007/BF00144429</identifier><identifier>PMID: 8817179</identifier><language>eng</language><publisher>Dordrecht: Kluwer Academic Publishers</publisher><subject>Antibodies, Fungal - classification ; Antifungal Agents - pharmacology ; Antifungal Agents - therapeutic use ; Antifungals ; Application programming interfaces ; Biological and medical sciences ; Candida ; Candida - classification ; Candida - drug effects ; Candida - immunology ; Candida albicans ; Candidiasis - drug therapy ; Candidiasis - microbiology ; Diversity indices ; DNA fingerprinting ; Fundamental and applied biological sciences. Psychology ; Fungi ; Humans ; Microbial colonization ; Microbiology ; Miscellaneous ; Mycology ; Oral candidiasis ; Serotyping - methods ; Torulopsis ; Yeasts</subject><ispartof>European journal of epidemiology, 1996-02, Vol.12 (1), p.55-62</ispartof><rights>Copyright 1996 Kluwer Academic Publishers</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c363t-ead8e5f5875b5aec7f9656ff3f363f71e45c533ef37e4f16bd08368b8ef132b33</citedby><cites>FETCH-LOGICAL-c363t-ead8e5f5875b5aec7f9656ff3f363f71e45c533ef37e4f16bd08368b8ef132b33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/3582102$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/3582102$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3124722$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8817179$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Quindós, Guillermo</creatorcontrib><creatorcontrib>Lipperheide, Verónica</creatorcontrib><creatorcontrib>Barturen, Begoña</creatorcontrib><creatorcontrib>Alonso, Rocío</creatorcontrib><creatorcontrib>Bikandi, Joseba</creatorcontrib><creatorcontrib>San Millán, Rosario</creatorcontrib><creatorcontrib>Tellaetxe, Matilde</creatorcontrib><creatorcontrib>Ribacoba, Laureano</creatorcontrib><creatorcontrib>Pontón, José</creatorcontrib><title>A New Method of Antibiotyping Yeasts for Subspecies Discrimination and Distribution in Human Clinical Specimens</title><title>European journal of epidemiology</title><addtitle>Eur J Epidemiol</addtitle><description>A study of the antibiotypes of 764 isolates of the genera Candida and Torulopsis from different clinical specimens is reported. The typing method was based on the susceptibility results obtained by the standardized and partially automated kit ATB-Fungus (API-bioMérieux), giving to each strain a code of six figures, according to these criteria: susceptibility to 5-fluorocytosine, amphotericin B, nystatin, miconazole, econazole, and ketoconazole. Candida albicans serotypes were determined by the Candida Check test (Iatron, Japan). Twenty-six antibiotypes were found in C. albicans (482 isolates), 21 types in serotype A, and 15 in serotype B strains. Candida parapsilosis (115 isolates) was divided into 11 antibiotypes, Torulopsis glabrata (53 isolates) into five, Candida guilliermondii (36 isolates) into 10 and Candida tropicalis (31 isolates) into eight. Depending on the sample origin, 000000 (susceptibility to all the antifungals tested) was the predominant C. albicans antibiotype (92.9% of blood isolates, 41.2% of vaginal isolates, 33.3% of respiratory isolates, 31.01% or oral and digestive tract isolates, and 25.0% of nail and skin isolates). No predominant antibiotypes were found in strains from respiratory tract, skin ad nails. A reproducibility close to 99% was found with the test. Simplicity and standardization could make this method useful for typing Candida and Torulopsis isolates.</description><subject>Antibodies, Fungal - classification</subject><subject>Antifungal Agents - pharmacology</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Antifungals</subject><subject>Application programming interfaces</subject><subject>Biological and medical sciences</subject><subject>Candida</subject><subject>Candida - classification</subject><subject>Candida - drug effects</subject><subject>Candida - immunology</subject><subject>Candida albicans</subject><subject>Candidiasis - drug therapy</subject><subject>Candidiasis - microbiology</subject><subject>Diversity indices</subject><subject>DNA fingerprinting</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fungi</subject><subject>Humans</subject><subject>Microbial colonization</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Mycology</subject><subject>Oral candidiasis</subject><subject>Serotyping - methods</subject><subject>Torulopsis</subject><subject>Yeasts</subject><issn>0393-2990</issn><issn>0392-2990</issn><issn>1573-7284</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUFP3DAQhS3Uii60F85U8qHigJTW9sSxc9wu0K1EywF64BQ5ybg1SuzFdlTx75tlV3DsaaR53zyN3iPkhLPPnDH15esVY7wsS1EfkAWXCgoldPmGLBjUUIi6Zu_IUUoPjDHNanlIDrXmiqt6QcKS_sS_9AfmP6GnwdKlz651IT9tnP9N79GknKgNkd5Obdpg5zDRC5e66EbnTXbBU-P77SpH107PC-fpehqNp6vBedeZgd5uL0f06T15a82Q8MN-HpNfV5d3q3VxffPt-2p5XXRQQS7Q9BqllVrJVhrslK0rWVkLdpat4ljKTgKgBYWl5VXbMw2VbjVaDqIFOCZnO99NDI8TptyM89M4DMZjmFKjNEjQpfwvyGUltai2juc7sIshpYi22cwZmPjUcNZsa2hea5jhj3vXqR2xf0H3uc_6p71u0pyPjcZ3Lr1gwEWphJix0x32kHKIr_L8EWcC_gGWDpjW</recordid><startdate>19960201</startdate><enddate>19960201</enddate><creator>Quindós, Guillermo</creator><creator>Lipperheide, Verónica</creator><creator>Barturen, Begoña</creator><creator>Alonso, Rocío</creator><creator>Bikandi, Joseba</creator><creator>San Millán, Rosario</creator><creator>Tellaetxe, Matilde</creator><creator>Ribacoba, Laureano</creator><creator>Pontón, José</creator><general>Kluwer Academic Publishers</general><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19960201</creationdate><title>A New Method of Antibiotyping Yeasts for Subspecies Discrimination and Distribution in Human Clinical Specimens</title><author>Quindós, Guillermo ; Lipperheide, Verónica ; Barturen, Begoña ; Alonso, Rocío ; Bikandi, Joseba ; San Millán, Rosario ; Tellaetxe, Matilde ; Ribacoba, Laureano ; Pontón, José</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c363t-ead8e5f5875b5aec7f9656ff3f363f71e45c533ef37e4f16bd08368b8ef132b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Antibodies, Fungal - classification</topic><topic>Antifungal Agents - pharmacology</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Antifungals</topic><topic>Application programming interfaces</topic><topic>Biological and medical sciences</topic><topic>Candida</topic><topic>Candida - classification</topic><topic>Candida - drug effects</topic><topic>Candida - immunology</topic><topic>Candida albicans</topic><topic>Candidiasis - drug therapy</topic><topic>Candidiasis - microbiology</topic><topic>Diversity indices</topic><topic>DNA fingerprinting</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fungi</topic><topic>Humans</topic><topic>Microbial colonization</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Mycology</topic><topic>Oral candidiasis</topic><topic>Serotyping - methods</topic><topic>Torulopsis</topic><topic>Yeasts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Quindós, Guillermo</creatorcontrib><creatorcontrib>Lipperheide, Verónica</creatorcontrib><creatorcontrib>Barturen, Begoña</creatorcontrib><creatorcontrib>Alonso, Rocío</creatorcontrib><creatorcontrib>Bikandi, Joseba</creatorcontrib><creatorcontrib>San Millán, Rosario</creatorcontrib><creatorcontrib>Tellaetxe, Matilde</creatorcontrib><creatorcontrib>Ribacoba, Laureano</creatorcontrib><creatorcontrib>Pontón, José</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Quindós, Guillermo</au><au>Lipperheide, Verónica</au><au>Barturen, Begoña</au><au>Alonso, Rocío</au><au>Bikandi, Joseba</au><au>San Millán, Rosario</au><au>Tellaetxe, Matilde</au><au>Ribacoba, Laureano</au><au>Pontón, José</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A New Method of Antibiotyping Yeasts for Subspecies Discrimination and Distribution in Human Clinical Specimens</atitle><jtitle>European journal of epidemiology</jtitle><addtitle>Eur J Epidemiol</addtitle><date>1996-02-01</date><risdate>1996</risdate><volume>12</volume><issue>1</issue><spage>55</spage><epage>62</epage><pages>55-62</pages><issn>0393-2990</issn><issn>0392-2990</issn><eissn>1573-7284</eissn><abstract>A study of the antibiotypes of 764 isolates of the genera Candida and Torulopsis from different clinical specimens is reported. The typing method was based on the susceptibility results obtained by the standardized and partially automated kit ATB-Fungus (API-bioMérieux), giving to each strain a code of six figures, according to these criteria: susceptibility to 5-fluorocytosine, amphotericin B, nystatin, miconazole, econazole, and ketoconazole. Candida albicans serotypes were determined by the Candida Check test (Iatron, Japan). Twenty-six antibiotypes were found in C. albicans (482 isolates), 21 types in serotype A, and 15 in serotype B strains. Candida parapsilosis (115 isolates) was divided into 11 antibiotypes, Torulopsis glabrata (53 isolates) into five, Candida guilliermondii (36 isolates) into 10 and Candida tropicalis (31 isolates) into eight. Depending on the sample origin, 000000 (susceptibility to all the antifungals tested) was the predominant C. albicans antibiotype (92.9% of blood isolates, 41.2% of vaginal isolates, 33.3% of respiratory isolates, 31.01% or oral and digestive tract isolates, and 25.0% of nail and skin isolates). No predominant antibiotypes were found in strains from respiratory tract, skin ad nails. A reproducibility close to 99% was found with the test. Simplicity and standardization could make this method useful for typing Candida and Torulopsis isolates.</abstract><cop>Dordrecht</cop><pub>Kluwer Academic Publishers</pub><pmid>8817179</pmid><doi>10.1007/BF00144429</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0393-2990
ispartof European journal of epidemiology, 1996-02, Vol.12 (1), p.55-62
issn 0393-2990
0392-2990
1573-7284
language eng
recordid cdi_proquest_miscellaneous_78353845
source MEDLINE; SpringerNature Journals; JSTOR Archive Collection A-Z Listing
subjects Antibodies, Fungal - classification
Antifungal Agents - pharmacology
Antifungal Agents - therapeutic use
Antifungals
Application programming interfaces
Biological and medical sciences
Candida
Candida - classification
Candida - drug effects
Candida - immunology
Candida albicans
Candidiasis - drug therapy
Candidiasis - microbiology
Diversity indices
DNA fingerprinting
Fundamental and applied biological sciences. Psychology
Fungi
Humans
Microbial colonization
Microbiology
Miscellaneous
Mycology
Oral candidiasis
Serotyping - methods
Torulopsis
Yeasts
title A New Method of Antibiotyping Yeasts for Subspecies Discrimination and Distribution in Human Clinical Specimens
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T03%3A49%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20New%20Method%20of%20Antibiotyping%20Yeasts%20for%20Subspecies%20Discrimination%20and%20Distribution%20in%20Human%20Clinical%20Specimens&rft.jtitle=European%20journal%20of%20epidemiology&rft.au=Quind%C3%B3s,%20Guillermo&rft.date=1996-02-01&rft.volume=12&rft.issue=1&rft.spage=55&rft.epage=62&rft.pages=55-62&rft.issn=0393-2990&rft.eissn=1573-7284&rft_id=info:doi/10.1007/BF00144429&rft_dat=%3Cjstor_proqu%3E3582102%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15658263&rft_id=info:pmid/8817179&rft_jstor_id=3582102&rfr_iscdi=true